Clinical Trials Logo

Alopecia clinical trials

View clinical trials related to Alopecia.

Filter by:

NCT ID: NCT06157905 Completed - Clinical trials for Extensive Alopecia Areata

Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

Start date: August 6, 2022
Phase: Early Phase 1
Study type: Interventional

This clinical trial was conducted at the Dermatology department of Services hospital Lahore. Patients of extensive and treatment resistant Alopecia areata were enrolled after ethical approval and informed consent by non-probability consecutive sampling. Inclusion criteria: Treatment with oral tofacitinib citrate was initiated at 5 mg twice daily for six months. Scalp hair loss was calculated at 4, 12 and 24 weeks using the validated Severity of Alopecia Tool (SALT) score, which ranges from 0% to 100%. Regrowth rate: (initial SALT score - final SALT score)/(initial SALT score) × 100 was noted. Response time (time from initiation of treatment to any sign of hair regrowth) was noted. DLQI of patients before and after treatment were noted. Side effects were noted. Pre- and post-treatment photographs were taken. Patients were followed up for another 6 months to look for relapse. Data were entered and analyzed using SPSS 20. Means were calculated for quantitative variables, frequencies for qualitative data. Data were stratified for the role of effect modifiers.

NCT ID: NCT06149936 Not yet recruiting - Alopecia Areata Clinical Trials

Excimer Light(308) Therapy for Resistant Alopecia Areata

Start date: December 1, 2023
Phase:
Study type: Observational [Patient Registry]

This study aimed to evaluate the efficacy and safety of the 308-nm excimer lamp in resistant AA treated with topical minoxidil .

NCT ID: NCT06149221 Completed - Clinical trials for Androgenetic Alopecia

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp

NCT ID: NCT06146166 Recruiting - Hair Thinning Clinical Trials

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

Start date: February 22, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to assess how an oral herbal supplement influences hair density, shine, growth, and microbiome.

NCT ID: NCT06145672 Not yet recruiting - Alopecia Scar Clinical Trials

Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This study aim: is to completely hide the alopecic scars in a way that it will not be visible.

NCT ID: NCT06126965 Active, not recruiting - Clinical trials for Androgenetic Alopecia

Phase III Study of KX-826 With Adult Male Patients With AGA

Start date: December 29, 2021
Phase: Phase 3
Study type: Interventional

This is a phase III, multi-center, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of KX-826 for topical use in Chinese adult male patients with androgenetic alopecia (AGA).

NCT ID: NCT06120933 Completed - Hair Loss Clinical Trials

A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health

Start date: June 15, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to investigate the effectiveness of two Vitamins Revive hair supplements in promoting hair growth, reducing hair loss, and improving overall hair health. The products under assessment are Hair Nutra Growth and Hair Nutra Boost. The trial will assess the efficacy of the products to induce better hair growth, reduction in hair loss and shedding, increased hair thickness and fullness, and improvement in hair appearance and vitality over a 12-week testing period. Participants will complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12. Participants will also provide photos of their hair at Baseline, Week 4, Week 8, and Week 12.

NCT ID: NCT06118866 Recruiting - Clinical trials for Androgenetic Alopecia

A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia

Start date: September 11, 2023
Phase: Phase 2
Study type: Interventional

To investigate the efficacy of HMI-115 compared to placebo in treating Androgenic Alopecia patients for 24 weeks

NCT ID: NCT06112782 Completed - Androgenic Alopecia Clinical Trials

Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The study aims to assess the efficacy and safety of Keravive by Hydrafacial treatments and Keravive Peptide Spray for scalp health and enhancing hair quality in patients with androgenic alopecia. This study is intended to be a single arm study. Suitable subjects who meet all inclusion criteria and consented will undergo 3 in-office Keravive by Hydrafacial treatments at Day 0 and Weeks 4 and 8 in combination with daily application on Keravive Peptide Spray at home. Subjects will be assessed at Day 0, and Weeks 4, 8, and 20 by investigators using the Norwood Scale (males), Ludwig Classification (females), and a series of Likert scales for ranking improvement in scalp health and hair quality.

NCT ID: NCT06110377 Recruiting - Androgenic Alopecia Clinical Trials

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)

MMP
Start date: October 30, 2023
Phase: Phase 4
Study type: Interventional

This randomized clinical trial carried out on 60 Brazilian men, aged 18 to 65, with mild or moderate androgenetic alopecia. Two techniques for administering dutasteride will be compared, injected by syringes or needles or by needling through tattoo machines.